Browse > Article
http://dx.doi.org/10.15432/JKTO.2020.25.1.001

A Case Report of Symptom Improvement after lobectomy in Male Breast Cancer with Lung Metastasis Patient Treated with Korean Medicine based Integrative Cancer Treatment  

Ko, Eun ju (East west Cancer center, Daejeon Korean Medicine Hospital of Daejeon University)
Ha, Su-jeong (East west Cancer center, Daejeon Korean Medicine Hospital of Daejeon University)
Park, Ji-hye (East west Cancer center, Seoul Korean Medicine Hospital of Daejeon University)
Park, So-jung (East west Cancer center, Daejeon Korean Medicine Hospital of Daejeon University)
Lee, Yeon-weol (East west Cancer center, Daejeon Korean Medicine Hospital of Daejeon University)
Cho, Chong-kwan (East west Cancer center, Daejeon Korean Medicine Hospital of Daejeon University)
Yoo, Hwa-seung (East west Cancer center, Seoul Korean Medicine Hospital of Daejeon University)
Publication Information
Journal of Korean Traditional Oncology / v.25, no.1, 2020 , pp. 1-9 More about this Journal
Abstract
Objective: The purpose of this study is to report improvement of symptoms after lobectomy of male breast cancer lung metastasis treated with Korean Medicine based Integrative Cancer Treatment (ICT). Methods: A male left breast cancer patient diagnosed with metastasis on lung at July 2019. After Video assisted thoracic surgery (VATS) left lower lobe (LLL) lobectomy and En bloc wedge resection the patient visited the Daejeon korean medicine hospital of Daejeon university East West Cancer Center (EWCC) to treat operation-site (op-site) pain, dysphagia, anorexia with Korean Medicine Treatment. The patient was treated with Korean Medicine based ICT for an approximately 20 days. The clinical outcomes were measured by National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE), Numeral rating scale (NRS) and Eastern Cooperative Oncology Group (ECOG). The safety of treatment was verified by blood tests. Results: After treatment, op-site pain was improved from NRS 9 to 6, dysphagia and anorexia were relieved from NRS 9 to 2. And ECOG score of the patient was improved from grade 2 to 1. Conclusion: This case study suggests that Korean Medicine based ICT may help to improve post operative sequelae in metastatic lung cancer patient.
Keywords
Breast cancer; Lung metastasis; Lobectomy; Herbal Medicine; Quality of Life;
Citations & Related Records
연도 인용수 순위
  • Reference
1 National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE) v.5.0, 2017. Available from https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0/.
2 Gwak MD, Suh SY. The assessment tools in palliative medicine. Kor J Hosp Palliat Care 12:177-193, 2009.   DOI
3 Jung, K.H. Special Review: Personalized therapy for advanced breast cancer using molecular signatures. Korean J Med 77(1):26-34, 2009.
4 Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac surg 38:323-30, 1984.   DOI
5 Park, HR, Lee, EJ, Moon, SC. Inhibition of lung cancer growth by HangAmDan-B is mediated by macrophage activation to M1 subtype. Oncol Lett 13:2330-2336, 2017.   DOI
6 Yim MH, Shin JW, Son JY, Oh SM, Han SH, Cho JH, Cho CK, Yoo HS, Lee YW, Son CG. Soluble components of Hericium erinaceum induce NK cell activation via production of interleukin-12 in mice splenocytes. Acta Pharmacol Sin 28(6):901-907, 2007.   DOI
7 Choi W, Jung H, Kim K, Lee S, Yoon S, Park J, Kim S, Cheon S, Eo W, Lee S. Rhus verniciflua stokes against advanced cancer: a perspective from the Korean Integrative Cancer Center. Biomedicine and Biotechnology 2012:1-7, 2011.
8 Jo HG, Park AR, Choi JB. Analgesic Effects of the Combination of Aconitum Ciliare Tuber with Honey in the Rat Models of Peripheral Neuropathic Pain. The Society of Korean Medicine Rehabilitation 21(2):159-170, 2011.
9 김은곤, 박영업, 이광호, 이한배, 장성익, 김성균 등. 자하거 약침 투여후 기침 가래 증상이 호전된 폐렴 후유증 환자 2례. 대한약침학회학회지 6(3):65-73, 2003.
10 A Systematic Review and Meta-Analysis on Intervention Programs for the Patients with Lung Cancer Who Underwent Lung Resection 19(5):2765-2785, 2017.   DOI
11 Garaci E, Pica F, Rasi G, Favalli C. Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application. Int J Immunopharmacol 22:1067-1076, 2000.   DOI
12 Sasco AJ, Lowenfels AB, Pasker-de Jong J. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 53:538-49, 1993.   DOI
13 The Korean Breast Cancer Society. Survival analysis of Korean breast cancer patients diagnosied between 1993 and 2002-A nationwide study of the cancer registry. J Breast Cancer 9:214-29, 2006.   DOI
14 Bernard-Marty C, Cardoso F, Piccart MJ. Facts and controversies in systemic treatment of metastatic breast cancer. Oncologist 9:617-32, 2004.   DOI
15 Krishnan K, Khanna C, Helman LJ. The molecular biology of pulmonary metastasis. Thorac Surg Clin 16:115-124, 2006.   DOI
16 Friedel G, Pastorino U, Ginsberg RJ, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 22:335-344, 2002.   DOI
17 Grichnik KP, D’Amico TA. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Semin Cardiothorac Vasc Anesth 8:317-34, 2004.   DOI
18 N. Mujovic, D. Subotic, M. Ercegovac, A. Milovanovic, L. Nikcevic, V. Zug- ic, and D. Nikolic, Influence of pulmonary rehabilitation on lung function changes after the lung resection for primary lung cancer in patients with chronic obstructive pulmonary disease, Aging and disease 6(6):466-477, 2015.   DOI
19 J. A. Sloan, X. Zhao, P. J. Novotny, J. Wampfler, Y. Garces, M. M. Clark, and P. Uang, Relationship between deficits in overall quality of life and non-small-cell lung cancer survival, J. of Clinical Oncology 30(13):1498-1504, 2012.   DOI
20 Jung, Kyung Ju1 Lee, Young Sook, The Effect of a Breathing Exercise Intervention on Pulmonary Function after Lung Lobectomy 10(1):95-102, 2010.